Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19064439 | TOTAL REVERSE SHOULDER SYSTEMS AND METHODS | February 2025 | July 2025 | Allow | 5 | 1 | 1 | Yes | No |
| 18833945 | REPAIR DEVICE FOR PROXIMAL HUMERAL FRACTURE | July 2024 | April 2025 | Allow | 8 | 0 | 0 | No | No |
| 18761202 | TOTAL REVERSE SHOULDER SYSTEMS AND METHODS | July 2024 | August 2024 | Allow | 2 | 0 | 0 | No | No |
| 18605361 | TOTAL REVERSE SHOULDER SYSTEMS AND METHODS | March 2024 | May 2024 | Allow | 2 | 0 | 0 | No | No |
| 18440820 | METHODS, SYSTEMS AND DEVICES FOR PRE-OPERATIVELY PLANNED ADAPTIVE GLENOID IMPLANTS | February 2024 | August 2024 | Allow | 6 | 1 | 0 | No | No |
| 18405658 | Methods And Compositions For Promoting The Structural Integrity Of Scaffolds For Tissue Engineering | January 2024 | December 2025 | Abandon | 23 | 1 | 1 | No | No |
| 18404307 | HYDRAULIC TAPER SEPARATOR FOR ORTHOPAEDIC IMPLANT SYSTEMS AND METHODS OF DISASSEMBLY | January 2024 | August 2025 | Allow | 20 | 0 | 1 | No | No |
| 18542482 | SEALING MEMBER FOR PROSTHETIC HEART VALVE | December 2023 | June 2024 | Allow | 6 | 2 | 0 | No | No |
| 18379396 | Fixation Member With Separate Eyelet And Methods Of Use Thereof | October 2023 | February 2026 | Allow | 28 | 2 | 1 | Yes | No |
| 18481548 | Sealing Structures for Paravalvular Leak Protection | October 2023 | June 2025 | Allow | 20 | 2 | 1 | No | No |
| 18477342 | Controllable Expandable Catheter | September 2023 | July 2025 | Allow | 22 | 1 | 1 | Yes | No |
| 18470517 | CALCANEAL PROSTHESIS | September 2023 | March 2025 | Allow | 18 | 1 | 1 | Yes | No |
| 18367782 | PROSTHETIC KNEE IMPLANT SYSTEMS AND METHODS WITH LINKED TIBIAL ROTATION | September 2023 | November 2024 | Allow | 14 | 0 | 1 | No | No |
| 18456708 | EXPANDABLE IMPLANTABLE CONDUIT | August 2023 | October 2025 | Allow | 26 | 2 | 1 | Yes | No |
| 18236983 | MULTI-LAYERED COMPOSITE BIONIC SELF-RETAINING PROSTHESIS FOR FEMORAL SHAFT | August 2023 | April 2024 | Allow | 7 | 1 | 0 | No | No |
| 18454203 | APPARATUSES AND METHODS FOR IMPLANTING GLENOID PROSTHESES | August 2023 | March 2025 | Allow | 19 | 1 | 1 | No | No |
| 18360005 | ORTHOPAEDIC IMPLANT SYSTEMS INCLUDING INTERNAL NETWORKS AND METHODS OF REPAIR | July 2023 | July 2025 | Allow | 23 | 1 | 1 | Yes | No |
| 18223441 | LOW PROFILE TRANSCATHETER HEART VALVE | July 2023 | August 2025 | Allow | 25 | 2 | 1 | Yes | No |
| 18271029 | UNICOMPARTMENTAL TIBIAL COMPONENTS | July 2023 | March 2026 | Allow | 32 | 0 | 1 | No | No |
| 18213751 | IMPLANTABLE VEIN FRAME | June 2023 | August 2024 | Allow | 14 | 0 | 1 | No | No |
| 18337656 | Low Profile Expandable Heart Valve | June 2023 | September 2025 | Allow | 27 | 3 | 1 | Yes | No |
| 18334302 | Methods And Technology For Creating Connections And Shunts Between Vessels And Chambers Of Biologic Structures | June 2023 | April 2025 | Allow | 22 | 1 | 1 | Yes | No |
| 18330643 | TRANSCATHETER VALVE PROSTHESIS HAVING AN EXTERNAL SKIRT FOR SEALING AND PREVENTING PARAVALVULAR LEAKAGE | June 2023 | September 2025 | Allow | 27 | 4 | 1 | No | No |
| 18321797 | IMPLANTABLE DRUG ELUTING DEVICE COMPRISING A MICROPOROUS STRUCTURE | May 2023 | July 2024 | Allow | 14 | 1 | 1 | No | No |
| 18196474 | Press Fit Stem | May 2023 | February 2025 | Allow | 21 | 2 | 1 | Yes | No |
| 18194015 | SYSTEM, METHOD AND TREATMENT OF ANEURYSMS UTILIZING ENDOGRAPHS | March 2023 | October 2025 | Allow | 31 | 0 | 0 | No | No |
| 18187220 | Cuff Stitching Reinforcement | March 2023 | August 2025 | Allow | 28 | 2 | 1 | No | No |
| 18162570 | STENT | January 2023 | April 2025 | Allow | 26 | 4 | 1 | Yes | No |
| 18101381 | GLENOID IMPLANT | January 2023 | May 2024 | Allow | 15 | 1 | 1 | Yes | No |
| 18150254 | HUMERAL IMPLANT ANCHOR SYSTEM | January 2023 | March 2024 | Allow | 14 | 0 | 1 | No | No |
| 18012849 | DEVICE FOR SHAPING AND CUTTING A BONE GRAFT | December 2022 | March 2026 | Allow | 38 | 1 | 0 | No | No |
| 18145156 | Drug Eluting Balloon | December 2022 | February 2025 | Abandon | 26 | 2 | 1 | No | No |
| 18010370 | MODULAR REVERSE SHOULDER PROSTHESIS | December 2022 | November 2024 | Allow | 23 | 2 | 1 | Yes | No |
| 18063239 | STENTED HEART VALVE DEVICES AND METHODS FOR ATRIOVENTRICULAR VALVE REPLACEMENT | December 2022 | March 2025 | Allow | 28 | 3 | 0 | Yes | No |
| 18070558 | Robotic Shoulder Fracture Management | November 2022 | January 2024 | Allow | 13 | 0 | 0 | No | No |
| 17993713 | SUPRA AND SUB-ANNULAR MITRAL VALVE DELIVERY SYSTEM | November 2022 | April 2024 | Allow | 16 | 0 | 1 | No | No |
| 18058058 | TOTAL REVERSE SHOULDER SYSTEMS AND METHODS | November 2022 | April 2023 | Allow | 5 | 0 | 0 | No | No |
| 17999367 | ACUTE AND CHRONIC DEVICES FOR MODIFYING FLOW IN BODY LUMENS AND METHODS OF USE THEREOF | November 2022 | October 2025 | Allow | 35 | 0 | 0 | No | No |
| 17989112 | METHODS FOR DEPLOYMENT OF AN IMPLANT | November 2022 | September 2024 | Abandon | 22 | 3 | 1 | Yes | No |
| 18055539 | THREE-DIMENSIONAL POROUS STRUCTURES FOR BONE INGROWTH AND METHODS FOR PRODUCING | November 2022 | June 2024 | Allow | 19 | 1 | 1 | No | No |
| 18053917 | Transcatheter Prosthetic Atrioventricular Valve | November 2022 | February 2026 | Allow | 40 | 1 | 1 | No | No |
| 17979675 | ACCOMMODATING INTRAOCULAR LENS AND METHODS OF IMPLANTATION | November 2022 | July 2025 | Allow | 33 | 0 | 0 | No | No |
| 17975767 | AUGMENTED GLENOID WITH GROOVE | October 2022 | October 2024 | Allow | 23 | 2 | 1 | No | No |
| 17954175 | Covered Stent | September 2022 | May 2024 | Allow | 20 | 1 | 1 | Yes | No |
| 17914154 | COVERED STENT | September 2022 | October 2025 | Allow | 37 | 1 | 0 | No | No |
| 17950503 | BRANCHING STENT GRAFT WITH MECHANICAL INTERLOCK | September 2022 | July 2025 | Allow | 34 | 2 | 1 | Yes | No |
| 17900355 | UNIVERSAL ENDOVASCULAR GRAFTS | August 2022 | August 2024 | Allow | 23 | 2 | 0 | No | No |
| 17886925 | IMPLANTABLE VEIN FRAME | August 2022 | September 2023 | Allow | 13 | 2 | 1 | Yes | No |
| 17873436 | ORTHOPAEDIC IMPLANTS INCLUDING PERIPHERAL APERTURE ARRANGEMENTS | July 2022 | March 2025 | Allow | 31 | 2 | 1 | Yes | Yes |
| 17874077 | SYSTEMS AND METHODS FOR MANUFACTURING A STENT FRAME | July 2022 | August 2024 | Allow | 25 | 1 | 1 | No | No |
| 17794652 | ENDOPROSTHESIS AND METHOD OF MANUFACTURING AN ENDOPROSTHESIS | July 2022 | January 2026 | Abandon | 41 | 1 | 0 | No | No |
| 17868664 | INTRALUMINAL SUPPORT STRUCTURE AND PROSTHETIC VALVE FOR THE SAME | July 2022 | August 2024 | Abandon | 25 | 1 | 1 | Yes | No |
| 17812195 | SURGICAL IMPLANTS HAVING DELIVERY PORTS AND METHODS OF USING THE SAME | July 2022 | October 2025 | Abandon | 39 | 4 | 1 | No | No |
| 17811002 | IMPLANT FOR THE GLENO-HUMERAL JOINT | July 2022 | December 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17858631 | DELIVERY SYSTEM HAVING RETRACTABLE WIRES AS A COUPLING MECHANISM AND A DEPLOYMENT MECHANISM FOR A SELF-EXPANDING PROSTHESIS | July 2022 | June 2025 | Allow | 36 | 0 | 0 | No | No |
| 17841985 | MACHINE LEARNING BASED SYSTEMS AND METHODS FOR CREATING PERSONALIZED ENDOVASCULAR STENTS AND STENT GRAFTS | June 2022 | February 2026 | Abandon | 44 | 1 | 1 | No | No |
| 17841912 | ANCHORING OF A PROSTHETIC VALVE | June 2022 | March 2024 | Allow | 21 | 0 | 1 | No | No |
| 17785659 | SURGICAL INSTRUMENTS AND METHODS | June 2022 | February 2026 | Allow | 44 | 1 | 1 | Yes | No |
| 17785752 | GLENOID POSITIONING DEVICE | June 2022 | September 2024 | Allow | 27 | 4 | 0 | No | No |
| 17806002 | MEDICAL DEVICE FOR TREATING A HEART VALVE INSUFFICIENCY | June 2022 | January 2026 | Allow | 44 | 1 | 0 | No | No |
| 17833246 | SET OF TOOLS FOR INSTALLING AN IMPLANT | June 2022 | November 2022 | Allow | 5 | 0 | 1 | No | No |
| 17824625 | HEART VALVE PROSTHESIS ANCHORED TO INTERVENTRICULAR SEPTUM AND CONVEYING AND RELEASING METHOD THEREOF | May 2022 | October 2024 | Allow | 28 | 2 | 1 | No | No |
| 17750861 | DYNAMIC BIOACTIVE BONE GRAFT MATERIAL HAVING AN ENGINEERED POROSITY | May 2022 | December 2025 | Abandon | 43 | 2 | 1 | No | No |
| 17742773 | IMPLANT WITH ABILITY TO CAPTURE EXTRAVASATING FIXATION MEDIUM | May 2022 | November 2024 | Allow | 30 | 3 | 1 | No | No |
| 17662546 | MASKED INTRAOCULAR IMPLANTS AND LENSES | May 2022 | July 2025 | Allow | 38 | 4 | 0 | Yes | Yes |
| 17772849 | COMPOSITE DEMINERALIZED BONE MATRIX COMPOSITION CONTAINING BONE MINERAL COMPONENT AND METHOD FOR PRODUCING SAME | April 2022 | December 2025 | Allow | 43 | 0 | 1 | No | No |
| 17716291 | ROTATIONAL ALIGNMENT OF MEDICAL IMPLANT | April 2022 | August 2025 | Allow | 40 | 0 | 1 | No | No |
| 17656744 | CARPOMETACARPAL (CMC) IMPLANTS AND METHODS | March 2022 | August 2023 | Allow | 16 | 0 | 0 | No | No |
| 17704621 | Method of Preparing Joint Prosthesis With Infinitely Positionable Head | March 2022 | June 2025 | Allow | 39 | 0 | 1 | No | No |
| 17700310 | MEDICAL IMPLANTABLE DEVICES AND METHODS OF USING THE SAME | March 2022 | March 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17700121 | ORTHOPAEDIC SYSTEM WITH MEDIAL PIVOTING INSERT | March 2022 | June 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17653843 | HEART VALVES WITH INCREASED EFFECTIVE ORIFICE AREA | March 2022 | July 2024 | Allow | 28 | 1 | 1 | No | No |
| 17677730 | DEVICES, SYSTEMS, AND METHODS FOR REPAIRING SOFT TISSUE AND ATTACHING SOFT TISSUE TO BONE | February 2022 | January 2024 | Allow | 23 | 1 | 0 | No | No |
| 17633098 | BONE PLUG COMPRESSION INSTRUMENT | February 2022 | August 2025 | Allow | 42 | 1 | 0 | No | No |
| 17632528 | IMPLANT COMPRISING A PLURALITY OF HARDENING STATES | February 2022 | January 2026 | Allow | 47 | 1 | 0 | No | No |
| 17585889 | Augmented Glenoid Design | January 2022 | June 2024 | Allow | 28 | 2 | 1 | Yes | No |
| 17581278 | TIBIAL SUPPORT OF ARTIFICIAL KNEE JOINT | January 2022 | June 2024 | Allow | 29 | 2 | 1 | No | No |
| 17628753 | MULTI-DEGREE-OF-FREEDOM MYOELECTRIC ARTIFICIAL HAND CONTROL SYSTEM AND METHOD FOR USING SAME | January 2022 | January 2025 | Allow | 36 | 1 | 0 | No | No |
| 17577349 | Implantable Transcatheter Intracardiac Devices and Methods for Treating Incompetent Atrioventricular Valves | January 2022 | July 2024 | Allow | 30 | 1 | 1 | Yes | No |
| 17597215 | ORTHOPAEDIC IMPLANT TO ADMINISTER A MEDICAL SUBSTANCE | December 2021 | January 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17646266 | Device And Method For Improving The Function Of A Heart Valve | December 2021 | January 2025 | Allow | 37 | 2 | 1 | No | No |
| 17620250 | SEGMENTED COVERED STENT AND PREPARATION METHOD THEREFOR | December 2021 | May 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17536798 | Femoral Head Arthroplasty System | November 2021 | February 2025 | Allow | 39 | 3 | 1 | Yes | No |
| 17535050 | COMPOSITIONS AND METHODS FOR TREATING ROTATOR CUFF INJURIES | November 2021 | January 2024 | Abandon | 25 | 1 | 0 | No | No |
| 17521637 | IMPLANT FOR TOTAL WRIST REPLACEMENT | November 2021 | July 2024 | Allow | 32 | 2 | 0 | No | No |
| 17517215 | Patient-Adapted and Improved Orthopedic Implants, Designs and Related Guide Tools | November 2021 | October 2025 | Abandon | 47 | 1 | 1 | No | No |
| 17516316 | GLENOID AUGMENTATION USING SOFT TISSUE GRAFT | November 2021 | September 2024 | Allow | 34 | 2 | 1 | Yes | No |
| 17594573 | GLENOID IMPLANT | October 2021 | November 2022 | Allow | 12 | 1 | 1 | Yes | No |
| 17604300 | SET OF TOOLS FOR INSTALLING AN IMPLANT | October 2021 | July 2024 | Allow | 33 | 0 | 1 | No | No |
| 17487232 | LIMITED EXPANSION HEART VALVES | September 2021 | January 2026 | Allow | 52 | 3 | 1 | No | No |
| 17479926 | TANDEM MODULAR ENDOGRAFT | September 2021 | September 2024 | Allow | 36 | 2 | 1 | No | No |
| 17479166 | Prosthetic Heart Valves And Apparatus And Methods For Delivery Of Same | September 2021 | February 2024 | Abandon | 29 | 0 | 1 | No | No |
| 17438208 | ORTHOPAEDIC SYSTEM WITH INSERT HAVING A POST FOR MEDIAL PIVOTING OF A FEMORAL COMPONENT | September 2021 | July 2025 | Allow | 46 | 1 | 1 | No | No |
| 17471506 | TRIAL RADIAL HEAD IMPLANT | September 2021 | May 2023 | Allow | 20 | 0 | 0 | No | No |
| 17462422 | ORTHOPAEDIC PROSTHESIS HAVING SUPPORT STRUCTURE | August 2021 | January 2024 | Allow | 29 | 1 | 1 | No | No |
| 17444587 | Differential Drive | August 2021 | August 2024 | Allow | 36 | 2 | 1 | No | No |
| 17390106 | ROTATOR CUFF CABLE RECONSTRUCTIONS | July 2021 | July 2024 | Allow | 35 | 3 | 1 | No | No |
| 17383332 | DEVICES, SYSTEMS AND METHODS FOR MONITORING HIP REPLACEMENTS | July 2021 | March 2024 | Allow | 32 | 2 | 0 | No | No |
| 17381358 | Low Profile Expandable Heart Valve | July 2021 | April 2023 | Allow | 21 | 0 | 1 | No | No |
| 17380377 | SYSTEMS, DEVICES, AND METHODS FOR THE ACCURATE DEPLOYMENT OF AN IMPLANT IN THE PROSTATIC URETHRA | July 2021 | April 2024 | Allow | 33 | 1 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HU, ANN M.
With a 57.1% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 23.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HU, ANN M works in Art Unit 3774 and has examined 954 patent applications in our dataset. With an allowance rate of 65.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.
Examiner HU, ANN M's allowance rate of 65.3% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by HU, ANN M receive 2.94 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HU, ANN M is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +24.2% benefit to allowance rate for applications examined by HU, ANN M. This interview benefit is in the 70% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 23.6% of applications are subsequently allowed. This success rate is in the 33% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 14.0% of cases where such amendments are filed. This entry rate is in the 15% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 146.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 89% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 92.8% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 53.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 44.0% are granted (fully or in part). This grant rate is in the 37% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 3.6% of allowed cases (in the 81% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.3% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.